Saturday 17 October 2026
Export MGTX’s income statement to Excel — free account
MeiraGTx Holdings PLC
MGTX Healthcare Biotechnology
MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.
9.28
0.61
−6.17%
Follow MGTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 3 | 1 | 2 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Altman Z-Score |
(4.39) | (3.99) | (2.11) | (2.07) | 2.98 | 1.93 | 2.38 | — | — | — |
P/S ratio |
7.86 | 12.78 | 29.54 | 18.39 | 27.79 | 36.70 | 49.95 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(14.65) | (10.70) | (5.72) | (5.17) | (1.19) | 2.45 | 2.70 | — | — | — |
Beneish M-Score |
(3.01) | (1.37) | (2.41) | (3.52) | (2.71) | (1.83) | — | — | — | — |
P/Operating CF |
13.71 | (18.27) | (28.46) | (18.00) | 55.66 | (19.32) | (30.22) | — | — | — |
P/B ratio |
0.00 | 6.27 | 3.00 | 2.49 | 5.65 | 2.39 | 3.48 | — | — | — |
Price to Tangible BV |
0.00 | 6.35 | 3.02 | 2.52 | 5.71 | 2.42 | 3.49 | — | — | — |
EV/Sales |
7.66 | 11.86 | 26.36 | 16.68 | 24.68 | 24.50 | 34.47 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
(13.44) | (3.78) | (3.51) | (3.63) | (88.37) | (5.96) | 22.86 | — | — | — |
EV/FCF |
(12.45) | (3.61) | (2.94) | (2.25) | (16.36) | (4.49) | 41.41 | — | — | — |
Quick Ratio |
0.69 | 1.86 | 2.28 | 1.76 | 2.54 | 4.82 | 5.34 | 4.61 | 0.40 | 2.89 |
Current Ratio |
0.75 | 2.03 | 2.38 | 1.88 | 2.69 | 5.03 | 5.47 | 4.82 | 0.54 | 3.16 |
Net Debt/EBITDA |
0.18 | 0.20 | 0.36 | 0.25 | 1.81 | 3.26 | 3.67 | 0.89 | 0.27 | 0.88 |
Debt/Assets |
20.37% | 27.14% | 26.04% | 27.77% | 6.36% | 5.41% | 6.64% | 0.01% | 0.13% | 0.02% |
Debt/Equity |
(8.60) | 1.08 | 0.62 | 0.75 | 0.11 | 0.08 | 0.11 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.32 | 0.11 | 0.04 | 0.05 | 0.11 | 0.05 | 0.06 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.41 | 0.71 | 1.25 | 0.56 | 0.13 | 1.10 | (0.37) | 0.70 | 0.57 | 0.73 |
Capex/Depreciation |
(0.27) | (0.35) | (1.35) | (4.82) | (5.78) | (5.35) | (3.97) | (5.59) | (15.08) | (9.96) |
Interest Coverage |
(8.69) | (12.37) | (10.35) | (23.53) | (252.63) | (450.03) | (1,198.93) | (2,338.45) | (738.57) | (789.94) |
| (368.19%) | (143.48%) | (65.67%) | (85.52%) | (37.53%) | (27.01%) | (40.28%) | (502.59%) | 98.76% | 60.68% | |
| (44.42%) | (49.55%) | (26.06%) | (40.61%) | (23.27%) | (16.87%) | (26.02%) | (137.96%) | (131.60%) | (80.87%) | |
ROIC |
0.00% | (274.50%) | (91.44%) | (80.28%) | (66.82%) | (80.27%) | 0.00% | (375.89%) | 0.00% | 0.00% |
Return on Tangible Assets |
(152.94%) | (89.24%) | (40.31%) | (71.40%) | (41.66%) | (22.09%) | (22.47%) | (104.32%) | (735.79%) | (121.83%) |
Average Days of Receivables |
82.00 | 106.15 | 609.72 | 665.41 | 339.02 | 1,205.70 | 969.67 | 0.00 | — | — |
Research and Development Expense of Revenue |
159.25% | 359.04% | 740.42% | 538.47% | 176.90% | 217.89% | 187.15% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
64.99% | 162.91% | 337.40% | 292.40% | 116.08% | 284.05% | 351.22% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
27.16% | 75.70% | 197.73% | 179.79% | 55.13% | 118.34% | 119.84% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.25) | (0.18) | (0.07) | (0.16) | 0.05 | 0.26 | 0.20 | — | — | — |
Graham Number |
1.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
(17.86%) | (34.98%) | (20.05%) | (44.29%) | (7.62%) | (10.17%) | (8.34%) | — | — | — |
Free Cash Flow Yield |
(7.83%) | (25.74%) | (30.32%) | (40.33%) | (5.43%) | (14.86%) | 1.67% | — | — | — |
Revenue per Share |
1.01 | 0.48 | 0.25 | 0.35 | 0.85 | 0.41 | 0.40 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.58) | (1.50) | (1.87) | (1.62) | (0.24) | (1.70) | 0.60 | (3.11) | (2.11) | (1.79) |
Capex per Share |
(0.05) | (0.07) | (0.36) | (1.00) | (1.05) | (0.61) | (0.27) | (0.59) | (1.23) | (0.32) |
Free Cash Flow per Share |
(0.62) | (1.57) | (2.22) | (2.61) | (1.29) | (2.31) | 0.33 | (3.70) | (3.34) | (2.12) |
Cash per Share |
0.82 | 1.48 | 2.29 | 2.56 | 3.12 | 5.55 | 6.85 | 3.59 | 1.00 | 2.18 |
Shareholders Equity per Share |
(0.07) | 0.97 | 2.45 | 2.61 | 4.20 | 6.32 | 5.75 | 4.28 | (5.53) | (2.14) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.07) | 0.97 | 2.45 | 2.61 | 4.20 | 6.32 | 5.75 | 4.28 | (5.53) | (2.14) |
Free Cash Flow |
(50.06) | (109.45) | (125.54) | (118.06) | (56.88) | (87.02) | 11.06 | (70.15) | (28.59) | (16.96) |
Working Capital |
(30.79) | 62.74 | 92.54 | 72.27 | 115.12 | 218.43 | 219.78 | 59.15 | (9.93) | 13.05 |
Capital Expenditures |
(3.70) | (4.95) | (20.17) | (44.96) | (46.35) | (23.05) | (8.98) | (11.26) | (10.54) | (2.59) |
Net Current Asset Value |
(158.46) | (78.41) | (28.94) | (46.16) | 48.48 | 147.44 | 135.89 | 58.82 | (61.74) | (20.60) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.05 | 0.15 | 1.44 | 2.82 | 1.23 | 1.48 | 0.68 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.14 | 0.13 | 0.09 | 0.11 | 0.10 | 0.09 | 0.09 | 0.05 | 0.09 |
Cash ROIC |
(45.53%) | (44.73%) | (35.58%) | (36.71%) | (16.56%) | (18.60%) | 2.52% | (47.03%) | 73.72% | (4,945.07%) |
Accounts Receivable Turnover |
5.82 | 2.01 | 0.53 | 0.50 | 0.87 | 0.36 | 0.69 | 0.00 | — | — |
Accounts Payable Turnover |
0.29 | 1.20 | 0.00 | 0.55 | 0.70 | 0.00 | 0.00 | 0.41 | 0.16 | 0.06 |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
758.64 | 361.85 | 0.00 | 695.27 | 711.55 | 0.00 | 0.00 | 541.02 | 3,791.55 | 2,213.42 |
Days of Inventory on Hand |
0.00 | 5.91 | — | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
13.98 | 16.55 | 26.22 | 32.02 | 43.21 | 43.36 | 19.36 | 20.26 | — | — |
Average Payables |
16.83 | 19.81 | 16.33 | 15.98 | 11.24 | 5.45 | 3.40 | 5.05 | 4.26 | 4.26 |
Average Assets |
257.09 | 298.25 | 322.49 | 319.20 | 341.93 | 343.79 | 210.39 | 61.37 | 24.20 | 24.20 |
Average Common Equity |
31.02 | 103.00 | 127.96 | 151.57 | 211.98 | 214.68 | 135.93 | 16.85 | (32.25) | (32.25) |
Columns are period end dates